^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ION537

    i
    Other names: ION537
    Associations

    News

    Trials
    Company:
    Ionis, UT MD Anderson Cancer Center
    Drug class:
    YAP1 inhibitor, RNA interference
    Related drugs:
    Associations

    News

    Trials
    almost2years
    A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=15, Completed, Ionis Pharmaceuticals, Inc. | Recruiting --> Completed | N=102 --> 15 | Trial completion date: Jun 2023 --> Oct 2022 | Trial primary completion date: Jun 2023 --> Oct 2022
    Trial completion • Enrollment change • Trial completion date • Trial primary completion date • Metastases
    |
    YAP1 (Yes associated protein 1)
    |
    ION537